This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S

This molecule targets at type 2 diabetes - a single crystal study on (2R,3S,5R)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl] tetrahydro-2H-pyran-3-amine (Omarigliptin), C17H20F2N4O3S

C17H20F2N4O3S, triclinic, P1 (no. 1), a = 6.0020(12) Å, b = 6.7650(14) Å, c = 11.831(2) Å, α = 89.39(3)°, β = 86.29(3)°, γ = 66.50(3)°, V = 439.55(15) Å3, Z = 1, Rgt(F) = 0.0543, wRref(F2) = 0.1568, T = 293(2) K.

Bibliographic Details
Main Authors: Wang Kun-Yan, Yang Xiao-Li
Format: Article
Language:English
Published: De Gruyter 2016-09-01
Series:Zeitschrift für Kristallographie - New Crystal Structures
Subjects:
1463122
Online Access:https://doi.org/10.1515/ncrs-2015-0260
Description
Summary:C17H20F2N4O3S, triclinic, P1 (no. 1), a = 6.0020(12) Å, b = 6.7650(14) Å, c = 11.831(2) Å, α = 89.39(3)°, β = 86.29(3)°, γ = 66.50(3)°, V = 439.55(15) Å3, Z = 1, Rgt(F) = 0.0543, wRref(F2) = 0.1568, T = 293(2) K.
ISSN:1433-7266
2197-4578

Similar Items